Federico Grossi - 14 May 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol
APLS
Transactions as of
14 May 2021
Net transactions value
-$22,695
Form type
4
Filing time
18 May 2021, 16:06:16 UTC
Next filing
15 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $22,695 -500 -0.89% $45.39 55,430 14 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.
F2 This included 316 shares from 4/30/21 ESPP purchase.